ABBV - AbbVie Inc.

NYSE - NYSE Delayed price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 235.43B
Enterprise value 290.80B
Trailing P/E 31.40
Forward P/E 12.22
PEG ratio (5-yr expected) 10.18
Price/sales (ttm)4.18
Price/book (mrq)17.74
Enterprise value/revenue 5.13
Enterprise value/EBITDA 14.69

Trading information

Stock price history

Beta (5Y monthly) 0.55
52-week change 3-6.59%
S&P500 52-week change 33.90%
52-week high 3168.11
52-week low 3131.10
50-day moving average 3152.18
200-day moving average 3150.61

Share statistics

Avg vol (3-month) 36M
Avg vol (10-day) 37.21M
Shares outstanding 51.76B
Implied shares outstanding 6N/A
Float 81.76B
% held by insiders 10.13%
% held by institutions 171.46%
Shares short (14 May 2023) 411.97M
Short ratio (14 May 2023) 42.2
Short % of float (14 May 2023) 40.68%
Short % of shares outstanding (14 May 2023) 40.68%
Shares short (prior month 13 Apr 2023) 415.14M

Dividends & splits

Forward annual dividend rate 45.92
Forward annual dividend yield 44.44%
Trailing annual dividend rate 35.78
Trailing annual dividend yield 34.33%
5-year average dividend yield 44.46
Payout ratio 4134.35%
Dividend date 314 May 2023
Ex-dividend date 412 Apr 2023
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Mar 2023


Profit margin 13.37%
Operating margin (ttm)36.98%

Management effectiveness

Return on assets (ttm)9.44%
Return on equity (ttm)51.28%

Income statement

Revenue (ttm)56.74B
Revenue per share (ttm)32.04
Quarterly revenue growth (yoy)-9.70%
Gross profit (ttm)41.53B
Net income avi to common (ttm)7.54B
Diluted EPS (ttm)4.24
Quarterly earnings growth (yoy)-94.70%

Balance sheet

Total cash (mrq)6.72B
Total cash per share (mrq)3.81
Total debt (mrq)62.46B
Total debt/equity (mrq)469.53
Current ratio (mrq)0.96
Book value per share (mrq)7.53

Cash flow statement

Operating cash flow (ttm)24.23B
Levered free cash flow (ttm)21.6B